RCVR (Residual CardioVascular Risk) Prospective Multicenter Study

CHA University

Status

Enrolling

Conditions

Coronary Artery Disease

Treatments

Other: DICOM Dataset

Diagnostic Test: Blood Sample

Study type

Observational

Funder types

Other

Identifiers

NCT06619353

CHAMC IRB 2024-01-054-004

Details and patient eligibility

About

The observational study aims to evaluate the long-term effects of residual cardiovascular risk on clinical outcomes following percutaneous coronary intervention (PCI). This risk includes thrombotic, metabolic, inflammatory, and procedural factors, which are assessed 1 month after the intervention. The primary question the study seeks to answer is:

What residual cardiovascular risk affects long-term clinical outcomes in patients undergoing PCI?

Participants will undergo artificial intelligence-based quantitative coronary analysis after PCI and will have comprehensive laboratory tests conducted at 1 month to evaluate residual cardiovascular risk, and then annually for 3 years post-intervention to assess changes in this risk.

Enrollment

1,000 estimated patients

Sex

All

Ages

20 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Patients who have undergone percutaneous coronary intervention.
Patients who have provided written informed consent.

Exclusion criteria

Under 19 years of age.
Pregnant, breastfeeding, or women of childbearing age.
Currently has a malignancy or has a history of malignancy within the past 5 years.
Life expectancy of less than 5 years.